Axogen, Inc. Encourages Peter J. Mariani to Government Vice President and Main Economical Officer
4 min readALACHUA, Fla., March 01, 2021 (World NEWSWIRE) — AxoGen, Inc. (NASDAQ: AXGN), a world leader in establishing and internet marketing progressive surgical alternatives for peripheral nerve accidents, nowadays declared the promotion of Peter J. Mariani to Government Vice President and Main Fiscal Officer.
Mr. Mariani has served as Axogen’s Chief Financial Officer considering the fact that 2016. For the duration of this time, he has played a critical part in the execution of Axogen’s method and in creating the foundation for lengthy-expression development, overseeing a quantity of initiatives that have strengthened the company’s money composition, improved administration procedures, and expanded the company’s services and capabilities.
“Pete’s leadership has had a meaningful impression on our company about the previous five yrs,” explained Karen Zaderej, chairman, CEO, and president of Axogen, Inc. “The capacity to understand the comprehensive opportunity of our growth possibility is pushed by ongoing self-control in our company procedures, resource allocation, and the execution of our important strategic initiatives. This expanded position recognizes Pete’s considerable and ongoing contributions to Axogen’s advancement and supplies an opportunity for him to generate further advancements that support our potential to achieve our mission.”
In his expanded job, Mr. Mariani will oversee the company’s Excellent Assurance workforce in addition to his recent organizational obligations, which involve oversight of the Finance and Accounting, Investor Relations, Info Technology, and Plan Administration capabilities.
About Axogen

Axogen (AXGN) is the major organization targeted specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and restore. Axogen staff are passionate about assisting to restore peripheral nerve purpose and excellent of existence to clients with bodily destruction or transection to peripheral nerves by delivering innovative, clinically demonstrated, and economically powerful restore remedies for surgeons and health and fitness care suppliers. Peripheral nerves deliver the pathways for both motor and sensory alerts during the human body. Each individual day, people go through traumatic injuries or undergo surgical strategies that impact the purpose of their peripheral nerves. Physical hurt to a peripheral nerve, or the incapability to thoroughly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of suffering.
Axogen’s platform for peripheral nerve fix capabilities a extensive portfolio of merchandise, together with Avance® Nerve Graft, a biologically energetic off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without having the comorbidities related with a 2nd surgical web page Axoguard Nerve Connector®, a porcine submucosa extracellular matrix (ECM) coaptation assist for tensionless maintenance of severed peripheral nerves Axoguard Nerve Protector®, a porcine submucosa ECM item utilised to wrap and defend damaged peripheral nerves and reinforce the nerve reconstruction when avoiding tender tissue attachments Axoguard Nerve Cap®, a porcine submucosa ECM item applied to safeguard a peripheral nerve conclusion and individual the nerve from the surrounding surroundings to lower the progress of symptomatic or unpleasant neuroma and Avive® Soft Tissue Membrane, a processed human umbilical twine meant for surgical use as a resorbable smooth tissue barrier. The Axogen portfolio of products and solutions is readily available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and numerous other countries.
Cautionary Statements About Ahead-Looking Statements

This press release includes “forward-looking” statements as outlined in the Personal Securities Litigation Reform Act of 1995. These statements are primarily based on management’s present-day expectations or predictions of long run problems, occasions, or results based on various assumptions and management’s estimates of developments and financial components in the marketplaces in which we are lively, as perfectly as our company programs. Words and phrases these as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “projects,” “forecasts,” “continue,” “may,” “should,” “will,” “goals,” and variations of these kinds of terms and similar expressions are supposed to discover this kind of forward-searching statements. The ahead-wanting statements may perhaps contain, with no limitation, statements associated to the predicted influence of COVID-19 on our small business, statements concerning our advancement, product development, item probable, fiscal functionality, revenue progress, product or service adoption, sector awareness of our items, info validation, our assessment of our interior controls in excess of fiscal reporting, our visibility at and sponsorship of conferences and educational occasions. The ahead-hunting statements are and will be matter to risks and uncertainties, which might trigger actual effects to differ materially from all those expressed or implied in such forward-looking statements. Ahead-looking statements contained in this press release must be evaluated with each other with the quite a few uncertainties that have an impact on our small business and our sector, especially people discussed underneath Component I, Product 1A., “Risk Elements,” of our Annual Report on Form 10-K, as amended on Variety 10-K/A, for the fiscal calendar year ended December 31, 2020, as nicely as other hazards and cautionary statements set forth in our filings with the U.S. Securities and Trade Commission. Forward-seeking statements are not a guarantee of long run performance, and actual benefits may perhaps differ materially from individuals projected. The ahead-hunting statements are agent only as of the date they are designed and, other than as expected by relevant law, we assume no obligation to publicly update or revise any forward-searching statements, regardless of whether as a outcome of new data, long term occasions, altered situation, or if not.
Speak to:

Axogen, Inc.
Peter J. Mariani, Main Economic Officer
[email protected]
[email protected]
